Telehealth ADHD Prescribing: What Psychiatric NPs Can Do in Florida

If you’re a psychiatrist or PMHNP wondering whether you can legally prescribe Adderall, Ritalin, or other ADHD medications through telehealth — and whether it’s worth building a practice around — you’re asking the right questions.

The short answer: Yes, psychiatrists can prescribe ADHD stimulants via telehealth in 2026, but the rules are complicated, constantly shifting, and vary significantly by state and provider type. Whether you’re an established psychiatrist looking to expand into telehealth or a PMHNP navigating scope-of-practice restrictions, understanding the current regulatory landscape is critical.

Here’s what you actually need to know about telehealth ADHD prescribing — the federal rules, state-by-state differences, what psychiatrists can do versus PMHNPs, and how the economics actually work.

The Federal Framework: Where Telehealth ADHD Prescribing Stands Right Now

The Ryan Haight Act and COVID-Era Waivers

Under normal circumstances, the Ryan Haight Act (2008) requires at least one in-person medical evaluation before a provider can prescribe Schedule II controlled substances like Adderall or Vyvanse via telemedicine. That rule was designed to prevent online ‘pill mills’ but created a major barrier to legitimate telehealth psychiatry.

During the COVID-19 Public Health Emergency, the DEA waived this requirement, allowing psychiatrists to initiate stimulant prescriptions entirely through video visits. That flexibility has been extended multiple times — most recently through December 31, 2025 — meaning psychiatrists could start ADHD patients on stimulants via telehealth throughout 2024-2025 without violating federal law.

The catch? As of early 2026, we’re in regulatory limbo. The latest extension was the third temporary measure, and unless Congress passes permanent legislation or the DEA issues new rules, the in-person requirement could snap back. The DEA has discussed creating a ‘special telemedicine registration’ pathway for controlled substance prescribing, but nothing concrete has been implemented yet.

What this means for you: Right now, you can prescribe ADHD meds via telehealth under the federal extension. But you should have a contingency plan — whether that’s partnering with local clinics for occasional in-person exams or being prepared to transition patients if rules change. Stay subscribed to DEA updates and professional org newsletters because this could shift in 2026.

Psychiatrists vs PMHNPs: Federal Authority Differences

From a federal standpoint, psychiatrists (MD/DO) with a valid DEA registration can prescribe any Schedule II-V medication — period. There’s no federal supervision requirement for physicians.

PMHNPs are a different story. While federal law doesn’t prohibit NPs from prescribing controlled substances (assuming they have DEA registration), state law determines whether they need physician oversight and what they can prescribe. We’ll dig into state-by-state rules below, but federally, the key point is: if you’re a psychiatrist, your authority is clear. If you’re an NP, you need to verify your state’s scope rules.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-by-State Reality: Where You’re Licensed Matters More Than You Think

Most content about telehealth prescribing gives you vague ‘check your state laws’ advice. Let’s get specific about the six states where most telehealth psychiatry happens: California, Texas, Florida, New York, Pennsylvania, and Illinois.

California: Transition to NP Independence (But You’re Not There Yet)

Psychiatrists: Full authority. California-licensed MDs can prescribe ADHD stimulants via telehealth without restrictions, following federal rules. The state doesn’t impose additional in-person requirements.

PMHNPs: California is transitioning toward full practice authority under AB 890 (passed 2020). As of 2023, experienced NPs with ≥3 years and 4,600 hours can apply for ‘104 NP’ status and practice independently — including prescribing Schedule II stimulants. Until you hit that threshold, you need physician supervision.

California also requires NPs to complete a specialized pharmacology course to prescribe Schedule II drugs. If you’re a newly graduated PMHNP in California, expect 2-3 years of collaborative practice before independence.

Market reality: California has roughly 7,800 psychiatrists for 40 million people (about 1 per 5,000 residents), but distribution is terrible — Central Valley and rural areas are desperately underserved. Telehealth demand is massive, especially among tech-savvy urban populations seeking adult ADHD care. Competition is stiff in LA/SF, but if you can serve Medicaid or underserved regions via telehealth, patient volume won’t be your problem.

Texas: Psychiatrists Are Essential (NPs Can’t Prescribe Stimulants Outpatient)

Psychiatrists: Full authority for telehealth ADHD prescribing. Texas allows video-based controlled substance prescribing for psychiatric disorders (just not chronic pain management via telehealth, which doesn’t apply to ADHD).

PMHNPs: Here’s where it gets restrictive. Texas law prohibits NPs from prescribing Schedule II controlled substances in outpatient settings — the only exceptions are hospitalized patients (≥24 hours), emergency departments, or hospice care. That means a Texas PMHNP cannot write an Adderall prescription for a routine ADHD patient at home, even with a collaborative agreement.

If you’re an NP in Texas treating ADHD, you can handle therapy, psychoeducation, and non-stimulant medications (like atomoxetine or bupropion), but you’ll need a collaborating psychiatrist to write stimulant prescriptions. This makes psychiatrists absolutely critical in Texas telehealth models.

Market reality: Texas has one of the worst psychiatrist shortages in the country — roughly 1 psychiatrist per 9,000 residents, with 185 of 254 counties designated shortage areas. Demand for telepsychiatry is enormous, especially in rural and suburban areas. If you’re a psychiatrist licensed in Texas, you can build a full caseload quickly. If you’re an NP, you’ll need an MD partner to make ADHD medication management work.

Florida: NPs Need Supervision, But Psych NPs Get Special Treatment

Psychiatrists: Full telehealth prescribing authority. Florida explicitly allows Schedule II prescribing via telehealth for psychiatric disorders (codified in state law), so ADHD prescribing is clearly permitted.

PMHNPs: Florida requires physician collaboration for all NP practice (no independent practice for psychiatric NPs). Here’s the nuance: Florida law limits NPs to 7-day supplies of Schedule II drugs, which would make ADHD treatment impossible — except psychiatric nurses treating mental health conditions are exempt from this limit.

If you’re a PMHNP in Florida with a psychiatrist collaborator, you can prescribe 30-day supplies of Adderall for ADHD patients. You just can’t do it independently — you need a formal protocol with a supervising psychiatrist (who can oversee up to 4 NPs).

Market reality: Florida has about 1 psychiatrist per 8,577 residents (rank 42nd nationally) — another severe shortage state. High demand, especially in North Florida and rural areas. The state’s telehealth laws are actually quite progressive (they anticipated this issue and carved out the psychiatric exception), so it’s a workable environment if you have the right collaborative setup.

New York: NPs Gain Independence After 2 Years

Psychiatrists: Unrestricted telehealth prescribing. New York has no additional state barriers beyond federal law.

PMHNPs: New York uses a transitional independence model. New NPs must practice under a collaborative agreement with a physician for 3,600 hours (about 2 years full-time). After completing those hours, they can practice and prescribe completely independently, including Schedule II stimulants.

During the collaboration period, NPs can still prescribe ADHD meds — the supervising physician just needs to be available for consult. There are no prescription quantity limits like Texas or Florida. Once you hit 3,600 hours, you’re essentially equivalent to an MD for prescribing purposes.

Market reality: New York has one of the best psychiatrist-to-population ratios in the country (about 1:2,900), heavily concentrated in NYC metro. However, upstate rural areas (Adirondacks, North Country, Western NY) are shortage zones. Telehealth can bridge that gap. The state has strong parity laws and Medicaid covers telepsychiatry, making reimbursement solid. If you’re a PMHNP in NY, it’s one of the best states for scope of practice.

Critical compliance note: New York mandates PDMP checks before every Schedule II prescription and requires e-prescribing for all controlled substances. Build these into your workflow.

Pennsylvania: Collaboration Required, With Initial Prescription Limits

Psychiatrists: Full telehealth authority, no state restrictions beyond federal law.

PMHNPs: Pennsylvania requires collaborative agreements with physicians (no independent practice). The wrinkle: NPs can only prescribe 72-hour initial supplies of Schedule II drugs for new patients or new conditions, and must notify the collaborating physician within 24 hours. After that, they can prescribe 30-day supplies.

This creates a workflow challenge: either the NP starts with a 3-day supply and quickly loops in the psychiatrist, or the psychiatrist writes the initial prescription and the NP handles follow-ups. Either way, you need tight MD-NP coordination in Pennsylvania.

Market reality: Pennsylvania has moderate psychiatrist density (about 1:4,586) but huge urban-rural splits. Philadelphia and Pittsburgh are well-served; rural central and northern PA have major gaps. Telehealth can help, and PA Medicaid has strong telehealth coverage. If you’re a psychiatrist in PA, you’ll likely work with NP colleagues and need to factor in that 72-hour initial limit.

Illinois: Full Practice Authority After 4,000 Hours

Psychiatrists: Full independent prescribing via telehealth.

PMHNPs: Illinois has a pathway to full practice authority — NPs who complete 4,000 hours of clinical practice under physician collaboration plus 250 hours of additional training can apply for FPA and then practice independently, including prescribing Schedule IIs. Until then, you need a written collaborative agreement.

The collaborating physician must approve which controlled substances you can prescribe (usually specified in your agreement). After FPA, you’re autonomous — no supervision required for ADHD medication management.

Market reality: Illinois has about 1 psychiatrist per 5,800 residents (moderate, but concentrated in Chicago). Downstate Illinois is underserved. Telehealth parity is strong (both Medicaid and commercial). By 2026, many experienced PMHNPs in Illinois have achieved FPA, increasing the supply of independent ADHD prescribers. If you’re a newer NP, plan on 2+ years under collaboration before independence.

Quick Reference: State Prescribing Authority for ADHD Meds

What Psychiatrists Can Actually Do via Telehealth (Clinically and Legally)

From a clinical capability standpoint, psychiatrists can handle essentially every aspect of ADHD care via video:

• Diagnosis: Take detailed history, use standardized rating scales (ASRS for adults, Vanderbilt for kids), obtain collateral information from family/teachers, conduct mental status exam via video
• Treatment initiation: Start stimulant medication, explain risks/benefits, establish monitoring plan
• Medication adjustments: Titrate doses, switch formulations, manage side effects
• Ongoing monitoring: Monthly 15-minute med checks (typical for stimulant therapy), review symptoms and adherence
• Documentation and compliance: e-prescribe through EPCS-compliant platforms, check PDMP databases, coordinate with primary care for baseline vitals if needed

The only thing you can’t do via telehealth is hands-on physical exam — but ADHD diagnosis doesn’t require one. You might ask patients to self-report blood pressure/heart rate (stimulants can affect cardiovascular parameters) or coordinate a local PCP visit for baseline labs if you’re concerned about cardiac history. But routine ADHD care doesn’t need in-person procedures.

Best Practices to Stay Compliant and Defensible

Given the scrutiny on telehealth ADHD prescribing (especially after some high-profile cases of inappropriate prescribing by startup companies), psychiatrists should:

1. Document thoroughly: DSM-5 criteria for ADHD, functional impairment, rule out other causes (anxiety, trauma, sleep disorders that mimic ADHD)
2. Verify identity and location: Confirm patient location each visit (for licensure and legal compliance)
3. Check PDMP: Query your state prescription monitoring database before prescribing (mandatory in many states like NY, best practice everywhere)
4. Obtain informed consent: Discuss stimulant risks (abuse potential, cardiovascular effects, psychiatric side effects)
5. Schedule regular follow-ups: Monthly visits are standard for stimulant therapy (30-day supply = monthly touchpoints)
6. Coordinate care: Communicate with patient’s PCP, especially for comorbid conditions
7. Use validated assessment tools: Standardize your diagnostic approach (harder for auditors to challenge)
8. Document telehealth consent: Many states require explicit patient consent for telehealth services

These aren’t just box-checking exercises — they’re how you demonstrate that your telehealth ADHD practice meets the same standard of care as in-person treatment, which is the legal requirement in most states.

Reimbursement Reality: Will You Actually Get Paid for Telehealth ADHD Care?

Here’s the good news: Telehealth reimbursement parity for mental health services is nearly universal in 2026. Almost every state has either enacted parity laws or insurers have voluntarily aligned telehealth payments with in-person rates.

What Psychiatrists Can Expect to Earn

Medicare reimbursement (2024-2025 fee schedule):

• 99213 (15-min established patient med check): ~$89-95
• 99214 (25-min moderate complexity visit): ~$125-136
• 90792 (initial psychiatric diagnostic evaluation with med services): ~$188-202

Commercial insurance typically pays equal to or higher than Medicare — often 10-30% more depending on the plan and your contract. In high-cost markets like NYC or San Francisco, private payers may reimburse $150+ for a med check.

Medicaid pays significantly less — roughly $40-65 for a 15-minute visit in most states (about half Medicare rates). If you’re building a telehealth practice, you’ll likely need a mix of insurance types to make the economics work, or focus on commercial/Medicare patients.

The Math on Telehealth Psychiatry Income

Let’s be realistic about what a full telehealth ADHD medication management practice looks like:

Scenario: You conduct four 15-minute med checks per hour via telehealth (99213 code, standard for ADHD follow-ups).

• Medicare rate: $90/visit × 4 visits/hour = $360/hour gross
• Commercial rate (assuming 20% higher): $108/visit × 4 = $432/hour gross
• Medicaid rate: $50/visit × 4 = $200/hour gross

If you work 30 clinical hours per week at a Medicare/commercial mix, you’re looking at $400,000-500,000 gross annual revenue before overhead. Since telehealth eliminates office rent, your overhead is mainly malpractice insurance, software subscriptions, and administrative support — potentially 30-40% instead of 50-60% for traditional practice.

Important: These are gross numbers. Actual collections run about 85-95% of billed charges (accounting for denials, patient responsibility, etc.). And you need to factor in time for documentation, prior authorizations (stimulants often require PA for brand names), and no-show rates.

But the economics are favorable — especially compared to traditional outpatient psychiatry where you might only see 3-4 patients per hour due to travel between rooms, no-shows creating gaps, etc.

Psychiatrists Get Paid More Than Other Provider Types

This matters: Psychiatrists are reimbursed at the highest rate for psychiatric services compared to NPs, PAs, therapists, or psychologists. Medicare pays NPs at 85% of the physician rate unless you bill ‘incident to’ (which is complicated and often not applicable in telehealth). Many commercial payers do the same.

Your MD/DO credential is worth real money — both in per-visit reimbursement and in scope (you can bill E/M codes that therapists can’t, you can do initial evals that command higher fees, etc.).

The Real Economics: Patient Acquisition and Platform Models

Here’s where most ‘join our telehealth platform’ pitches get fuzzy. Let’s talk actual numbers.

The Patient Acquisition Cost Reality

If you were to build your own ADHD telehealth practice from scratch, acquiring patients is expensive and time-consuming:

SEO/Content Marketing:

• Timeline: 6-12 months before meaningful traffic
• Cost: $2,000-5,000/month for quality content, technical SEO, and link building
• Reality: Most solo psychiatrists lack the expertise and patience

Google Ads:

• Cost per click for ‘ADHD psychiatrist near me’: $15-40+
• Conversion rate (click to booked appointment): Often 5-15% for cold leads
• Realistic cost per booked patient: $200-400+
• Problem: You’re spending money on clicks that don’t convert, testing ad copy, managing campaigns

Psychology Today and Directories:

• Monthly fees: $30-50 for basic listing
• Featured listings: $100-200/month
• Patient acquisition: You compete with hundreds of providers on the same page
• Conversion rates: Highly variable

Zocdoc and Pay-Per-Booking Platforms:

• Booking fee: $35-100+ per appointment booked
• Monthly subscription: Often an additional $200-300
• Total monthly cost with decent volume: $1,000-3,000+

When you add it all up — agency fees, ad spend, directory subscriptions, time spent managing campaigns, no-shows from unqualified leads — the true cost of acquiring a psychiatric patient through DIY marketing is typically $200-500+ per new patient.

And that’s if you know what you’re doing. Most psychiatrists waste $3,000-5,000/month testing channels before finding what works.

The Platform Model Alternative

This is where platforms like Klarity Health offer a fundamentally different economic model:

Pay-per-appointment instead of pay-per-lead:

• You pay a standard fee per new patient appointment
• No upfront marketing spend
• No monthly subscriptions bleeding cash while you wait for SEO to work
• No wasted ad budget on clicks that don’t convert

Pre-qualified patient matching:

• Patients are already screened for insurance eligibility, location, and presenting concern
• You’re not fielding calls from people who can’t afford care or aren’t in your specialty
• Built-in scheduling system reduces no-show rates

Infrastructure included:

• HIPAA-compliant telehealth platform (no separate Zoom or Doxy.me subscription)
• E-prescribing integrated (EPCS-compliant for controlled substances)
• Billing support (or handle insurance credentialing if you prefer)
• Patient portal and documentation tools

The financial logic: Instead of gambling $3,000-5,000/month on marketing with uncertain ROI, you pay only when a qualified patient books with you. Guaranteed ROI versus marketing risk.

Example: If you see 20 new ADHD patients a month through a platform and each generates $180-200 in reimbursement for the initial eval (90792), even after the platform’s listing fee, you’re profitable from day one — with zero marketing headaches, no agency retainers, no ad spend testing.

Both Insurance and Cash-Pay Patients

Many telehealth platforms offer a mix:

• Insurance patients (Klarity credentials you with major payers, or you use existing contracts)
• Cash-pay patients (for those without coverage or who prefer privacy/convenience)

Cash rates for ADHD evaluations: typically $200-350. Follow-ups: $99-150. If even 20% of your patients are cash-pay, that’s additional margin without insurance overhead.

The key is patient volume without marketing burden. That’s what lets you scale.

Provider Demand and Market Conditions: Where the Opportunity Actually Is

Let’s cut through the generic ‘mental health crisis’ talk and look at real supply-demand dynamics.

States with the Biggest Shortages (Highest Opportunity)

Texas and Florida have the most severe psychiatrist shortages:

• Texas: ~1 psychiatrist per 9,000 residents (185 of 254 counties are shortage areas)
• Florida: ~1 per 8,577 residents

These states have massive unmet demand for ADHD services. However, they’re also restrictive for NPs (Texas especially), meaning psychiatrists are critically needed.

Pennsylvania and Illinois have moderate ratios (~1:4,500-5,800) but severe urban-rural splits. Rural central PA and downstate Illinois are underserved — telehealth can bridge that gap profitably.

California and New York have better overall ratios but still have shortage pockets (Central Valley CA, upstate NY) and enormous absolute demand due to population size.

Adult ADHD Is Driving Growth

During the pandemic, adult ADHD diagnoses surged. New prescriptions for stimulants used to treat ADHD increased dramatically in 2020-2022 — driven by telehealth access making it easier for adults (who previously couldn’t find time for in-person appointments) to seek evaluation.

This trend has continued post-pandemic. Young professionals, especially in tech hubs and urban areas, are seeking ADHD assessment and treatment in higher numbers than ever. The patient demand is real and sustained.

Medication Shortages: A Current Challenge

Since late 2022, Adderall and other stimulant shortages have been widely reported. The DEA had to raise manufacturing quotas in 2023-2024 to address demand. For providers, this means:

• Frustrated patients when pharmacies are out of stock
• Need to be flexible with alternative medications (different formulations, non-stimulants)
• More time coordinating with pharmacies

It’s not a reason to avoid ADHD prescribing — shortages are easing and it’s a solvable problem — but it’s a current reality that requires patient communication and flexibility.

Common Questions Psychiatrists and PMHNPs Are Asking

‘Can I prescribe Adderall via telehealth if I’ve never met the patient in person?’

Currently, yes (under the DEA extension through end of 2025), as long as you conduct a proper evaluation via video. After 2025, it depends on whether federal flexibility is extended or replaced. Monitor DEA announcements.

‘Do I need a separate DEA registration for telehealth prescribing?’

No. Your existing DEA registration covers telehealth prescribing as long as you’re licensed in the state where the patient is located. The proposed ‘special telemedicine registration’ hasn’t been implemented yet.

‘What if federal telehealth rules change mid-patient treatment?’

If the in-person requirement returns, you’d need to either: (a) arrange an in-person visit with the patient or a local provider, (b) transition the patient to a local prescriber, or (c) switch to non-controlled ADHD medications (atomoxetine, bupropion, or off-label options). Have a plan.

‘Can I practice telehealth across state lines?’

Only if you’re licensed in every state where your patients are located. You can’t treat a Texas patient unless you have a Texas medical license. Some states participate in interstate compacts (like the Interstate Medical Licensure Compact for physicians), which streamlines getting multiple licenses — but you still need the actual license.

‘What about liability? Is telehealth ADHD prescribing riskier?’

Malpractice risk exists whether you’re in-person or virtual. The key is practicing to the standard of care: thorough evaluation, proper documentation, appropriate monitoring, and avoiding ‘prescription factory’ behavior. Your malpractice insurance should cover telehealth (verify this — most policies now do). Practicing on a reputable platform that emphasizes quality and compliance actually reduces risk compared to solo practice without infrastructure.

‘How do I handle drug testing or physical exams via telehealth?’

Drug testing: If clinically indicated (e.g., suspected substance use comorbidity), you can order at-home test kits or refer to local labs. Most routine ADHD care doesn’t require drug screening unless there are red flags.

Physical exams: ADHD diagnosis is based on history and behavioral observation — no physical exam needed. For monitoring vitals (BP/HR), you can ask patients to use home monitors or get vitals checked at a pharmacy/PCP office. Document when and why you’re coordinating external services.

‘As a PMHNP, how do I find a collaborating psychiatrist in a restricted state?’

Some telehealth platforms (including Klarity) arrange physician collaborators for NPs in states that require it — that’s part of their value proposition. Alternatively, join a group practice where collaboration is built into the structure. Going solo in a restricted state means you need to recruit your own collaborating MD, which can be challenging.

Why Psychiatrists Should Consider Joining a Telehealth Platform

If you’re an established psychiatrist with a full in-person practice, telehealth might seem unnecessary. But consider:

Flexibility and lifestyle: See patients from home, eliminate commute time, set your own hours. Many psychiatrists use telehealth to ease into semi-retirement or balance childcare.

Geographic reach: Serve underserved areas without relocating. You can practice in rural Texas from your home in Austin, or cover upstate NY from Manhattan.

Lower overhead: No office lease, reduced staff costs, lower malpractice premiums (some carriers discount for non-procedure specialties).

Higher effective hourly rate: Four 15-minute appointments per hour is feasible with telehealth efficiency. In-person practices often struggle to hit 3/hour due to logistics.

Market demand: ADHD waitlists are 3-6 months in many areas. You can build volume quickly.

Recession-resistant: Mental health services, especially medication management for established conditions like ADHD, tend to be more stable than discretionary healthcare spending.

If you’re a newly minted psychiatrist or experienced PMHNP, telehealth platforms offer the fastest path to building a practice without the capital requirements of opening an office or the risk of marketing spend.

The Bottom Line: Can You Build a Sustainable Telehealth ADHD Practice?

Yes — if you navigate the regulations correctly and partner with the right platform.

Psychiatrists have clear authority in every state to prescribe ADHD medications via telehealth (within current federal rules). PMHNPs have that same authority in FPA states or with proper collaboration in restricted states.

The clinical work is straightforward — ADHD medication management is well-suited to video visits. Reimbursement is solid and likely to remain so with parity laws. Patient demand is high and sustained.

The challenges are:

1. Regulatory uncertainty (federal telehealth rules expire end of 2025 without extension)
2. State-specific scope restrictions (especially for NPs)
3. Patient acquisition cost (if you DIY)
4. Medication supply issues (shortages, though improving)

Joining a platform like Klarity addresses the biggest pain points: patient acquisition, infrastructure, and compliance support. Instead of spending $3,000-5,000/month gambling on marketing or $50,000-100,000 building your own telehealth infrastructure, you pay only when qualified patients book — and you can start seeing patients in weeks, not months.

For psychiatrists in shortage states (TX, FL, PA), demand will exceed your capacity to see patients. For PMHNPs in FPA states (NY, IL, CA after experience), you can build an independent practice with platform support. For NPs in restricted states, platforms that provide collaborating psychiatrists make practice feasible.

The economics work. The clinical model works. The question is whether you want to build the marketing and operational infrastructure yourself, or leverage a platform that’s already solved those problems.

Ready to Start Practicing Telehealth Psychiatry?

Klarity Health connects psychiatrists and PMHNPs with patients seeking ADHD evaluation and medication management via telehealth. We handle patient acquisition, credentialing, platform technology, and compliance support — you focus on clinical care.

How it works:

• Pay-per-appointment model (no upfront marketing costs or monthly subscriptions)
• Pre-qualified patients matched to your specialty, licensure, and availability
• Integrated telehealth platform with EPCS-compliant e-prescribing
• Support for both insurance and cash-pay patients
• Collaborative physician arrangements available for NPs in restricted states

For psychiatrists: You set your schedule, see patients from anywhere, and get paid for every visit — without spending thousands on ads or waiting months for SEO to work.

For PMHNPs: We help you navigate scope-of-practice requirements and provide collaboration where state law requires it, so you can focus on patient care.

Join Klarity’s provider network and start seeing ADHD patients this month — not six months from now after burning through your marketing budget.

[Explore Provider Opportunities at Klarity Health →]

Sources and Verification

This article is based on current federal and state regulations as of February 2026. All legal and regulatory statements have been verified against official sources. The following references were used:

Top 5 Key Citations:

1. DEA/HHS Extension of COVID-Era Telehealth Prescribing: The Drug Enforcement Administration and Department of Health & Human Services extended pandemic-era flexibilities allowing telehealth prescribing of controlled substances (including ADHD stimulants) through December 31, 2025. This marks the third temporary extension. (Source: Axios News, November 18, 2024. www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall)

2. Florida Telehealth Law – Psychiatric Exception for Schedule II Prescribing: Florida Statute §456.47 explicitly permits telehealth providers to prescribe Schedule II controlled substances when treating psychiatric disorders (among other specific exceptions), allowing psychiatrists and qualified psychiatric NPs to prescribe ADHD stimulants via telemedicine legally. (Source: Florida Statutes 2023, §456.47. www.flsenate.gov/Laws/Statutes/2023/456.47)

3. Texas NP Schedule II Prescribing Restriction: Texas law prohibits nurse practitioners from prescribing Schedule II controlled substances in outpatient settings except for hospitalized patients (≥24 hours), emergency department patients, or hospice/terminally ill patients — effectively barring NPs from routine outpatient ADHD stimulant prescribing. (Source: RxAgent ‘NP Prescriptive Authority by State 2026 Guide,’ December 28, 2025. rxagent.co/blog/np-prescribing-authority)

4. Surge in ADHD Prescriptions During Pandemic: Prescriptions for ADHD treatments surged during the COVID-19 pandemic, with new stimulant prescriptions increasing 45.5% between 2020-2021 as telehealth expanded access, according to FDA researchers. This trend reflects sustained high demand for ADHD services. (Source: Associated Press, January 10, 2024. apnews.com/article/228102e7d9a2e031b7b688d60faf208b)

5. Telehealth Reimbursement Parity – Near Universal Adoption: Telehealth payment parity for mental health services is ‘nearly universal’ across the United States by 2026, with 48 states having enacted parity laws or widespread insurer adoption, ensuring psychiatrists receive equal reimbursement for virtual and in-person medication management visits. (Source: BehaveHealth Mental Health Reimbursement 2024 Report. behavehealth.com/mental-health-reimbursement-2024)

Additional Sources:

All state-specific scope of practice, prescribing limits, and telehealth regulations were verified against official state statutes and regulatory board guidance current as of 2025-2026:

• California: AB 890 implementation (NP independent practice pathway); Schedule II prescribing requirements. Sources: [rxagent.co/blog

Source:

• https://www.axios.com/2024/09/18/telehealth-services-controlled-substances-congress#:~:text=Why%20it%20matters%3A%20Pandemic,end%20of%20this%20year%20after
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,the%20third%20temporary%20extension%20of
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=1,disorder
• https://rxagent.co/blog/np-prescribing-authority#:~:text=OK%20%20,day%20%28ongoing%29%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=TN%20%20,NP%3A%20Independent%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=match%20at%20L210%20NY%20,terminal%20illness%2C%20MD%20initiation
• https://rxagent.co/blog/np-prescribing-authority#:~:text=ID%20%20,3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=FL%20%20,NP%3A%20Independent%20%5B3
• https://www.leg.state.fl.us/STATUTeS/index.cfm?Appmode=DisplayStatute&Search_String=&URL=0400-0499%2F0464%2FSections%2F0464.012.html#:~:text=also%20limit%20the%20prescribing%20of,shall%20adopt%20by%20rule%20the